Search Results - "Diffuse large B-cell lymphoma"

Tumor Pro-Senescence Strategy to Enhance Mild Photothermal Therapy of Diffuse Large B‑Cell Lymphoma

Kang, Yehui^aff1, Yu, Liya^aff1, Chen, Yang^aff1, Zhao, Jiamei^aff1, Liu, Ziyang^aff1, Chen, Gongning^aff1, Hu, Xiaojuan^aff1, Mou, Xiaozhou^aff1, Cai, Yu^aff1, Tong, Xiangmin^{aff2, aff3}

Plant Virus Intratumoral Immunotherapy with CPMV and PVX Elicits Durable Antitumor Immunity in a Mouse Model of Diffuse Large B‑Cell Lymphoma

Affonso de Oliveira, Jessica Fernanda^{aff1, aff2, aff3, aff4}, Moreno-Gonzalez, Miguel A.^{aff1, aff2, aff3, aff4}, Ma, Yifeng^{aff1, aff2, aff3, aff4}, Deng, Xinyi^{aff1, aff2, aff3, aff4}, Schuphan, Juliane^aff9, Steinmetz, Nicole F.^{aff1, aff2, aff3, aff4, aff5, aff6, aff7, aff8}

Updates on the Treatment of Richters Syndrome, Including Novel Combination Approaches.

Jain, Tanim, Heyman, Benjamin

application/pdf

Prognosis Prediction of Diffuse Large B-Cell Lymphoma in $^{18}$F-FDG PET Images Based on Multi-Deep-Learning Models

Qian, C., Jiang, C., Xie, K., Ding, C., Teng, Y., Sun, J., Gao, L., Zhou, Z., Ni, X.

Genomic mutation profile and metabolic alterations in diffuse large B-cell lymphoma with abdominal bulky mass

Zhang, Han^Aff1, Zhang, Zijian^Aff1, Li, Liru^Aff1, Gao, Shiqi^Aff1, Jia, Fan^Aff2, Ma, Jianli, Liu, Mengmeng, Yang, Mingzhe, Sun, Ruiyang, Li, Hongbin, Zhao, Wenhui, Wang, Kezheng, Zhang, Yue^{Aff1, IDs00277025064101_cor1}, Zhang, Qingyuan^{Aff1, IDs00277025064101_cor2}, Zhao, Shu^{Aff1, IDs00277025064101_cor3}

Long-term follow-up of autologous hematopoietic cell transplantation for diffuse large B cell lymphoma in the rituximab era: real‑world data from a retrospective single‑center analysis

Li, Jiangtao^Aff1, Zhao, Fei^Aff1, Qian, Long, Yin, Jingjing, Yang, Yazi, Bai, Jiefei, Zhang, Chunli, Wang, Ting, Feng, Ru, Liu, Hui^{Aff1, Aff2, IDs0027702506430x_cor1}

Maligne B- und T-Zell-Lymphome in der neuen WHO-Klassifikation: Für die Klinik relevante Änderungen

Malignant B- and T-cell lymphoma in the new WHO classification: Clinically relevant changes

Hartmann, Sylvia^{Aff1, IDs00761025017054_cor1}, Klapper, Wolfram

The Improving Outcomes in Relapsed-Refractory Diffuse Large B Cell Lymphoma: The Role of CAR T-Cell Therapy

Milunović, Vibor^{Aff1, IDs11864025013059_cor1}, Dragčević, Dora, Bogeljić Patekar, Martina, Mandac Smoljanović, Inga, Gašparov, Slavko^{Aff2, Aff3}

Efficacy and safety of the thiotepa–busulfan conditioning regimen as for autologous stem cell transplantation in relapsed/refractory systemic diffuse large B cell lymphoma: a single-center retrospective study: Efficacy and safety of the thiotepa–busulfan conditioning…

Io, Katsuhiro^{Aff1, IDs1218502503946w_cor1}, Nagai, Kenichi, Kakihara, Bunta, Izumi, Kiyotaka, Kitagawa, Tomoya

Modulating JAK2/STAT3 signaling by quercetin in Qiling Baitouweng Tang: a potential therapeutic approach for diffuse large B-cell lymphoma

Zhan, Xin-Zhuo^{Aff1, Aff2}, Wei, Tian-Hua^Aff3, Huang, Chen, Yu, Hui, Chen, Xiao-Li, Kong, Xiang-Tu, Shang, Zhi-Hao, Sun, Shan-Liang^{Aff3, Aff5, IDs11030024109992_cor1}, Lu, Meng-Yi^{Aff6, IDs11030024109992_cor2}, Ni, Hai-Wen^{Aff1, IDs11030024109992_cor3}

Efficacy and safety of orelabrutinib combined with rituximab and high dose methotrexate in primary or secondary central nervous system diffuse large B-cell lymphoma: a retrospective analysis

Zhou, Jiahao^{Aff1, Aff2}, Xing, Lingxiao^{Aff1, Aff2, Aff3}, Miao, Yi^{Aff1, Aff2, Aff3}, Qin, Shuchao^{Aff1, Aff2, Aff3}, Zhang, Run^{Aff1, Aff2, Aff3}, Tang, Hanning^{Aff1, Aff2, Aff3}, Xu, Wei^{Aff1, Aff2, Aff3}, Xia, Yi^{Aff1, Aff2, Aff3, IDs10637025015427_cor1}, Zhu, Huayuan^{Aff1, Aff2, Aff3, IDs10637025015427_cor2}, Li, Jianyong^{Aff1, Aff2, Aff3, IDs10637025015427_cor3}

Staging und Therapieansprechen mit radiologischen und nuklearmedizinischen Verfahren bei Non-Hodgkin-Lymphomen (NHL)

Staging and treatment response assessment with radiological and nuclear medicine approaches for non-Hodgkin lymphomas

Neelsen, Christian, Mohammad, Ahmad^{Aff1, Aff2}, Schlemmer, Heinz-Peter, Dimitrakopoulou-Strauss, Antonia, Sachpekidis, Christos^{Aff3, IDs00117025014595_cor1}

Development and validation of a prognostic nomogram for diffuse large B-cell lymphoma: a multicenter cohort study from Northern China

Cui, Juya^Aff1, Wang, Tao^Aff2, Zhang, Junyan, Guo, Meiru, Zhu, Jun^{Aff4, IDs12094025039555_cor1}, Hou, Shuling^{Aff1, IDs12094025039555_cor2}

Diffuse Large B-Cell Lymphoma Developed Shortly After mRNA COVID-19 Vaccination in a Patient with Sickle Cell Disease: A Chicken-and-Egg Problem

Embaby, Ahmed^{Aff1, Aff2, IDs4441102500174w_cor1}, Ibrahim, Amro, Elsheikh, Haitham^{Aff1, Aff2}, AlMalki, Mazen, Kashif, Muhammad, Althomali, Muteb, Babateen, Ammar

Single-cell sequencing and spatial transcriptomics reveal FAS+ T cell and autophagy-related signatures predicting chemoimmunotherapy response in diffuse large B-cell lymphoma patients

Lou, Ning^{Aff1, Aff2}, Dai, Liyuan^Aff2, Gao, Ruyun^Aff2, Yang, Jianliang, Gui, Lin, Yang, Sheng, Liu, Peng, Shi, Yuankai^{Aff2, IDs1142702428492_cor1}, Han, Xiaohong^{Aff1, IDs1142702428492_cor2}

LILRB1 enhances the progression of diffuse large B-cell lymphoma through the CREB-SORBS3 pathway

Cao, Liyuan^Aff2, Zhao, Hanqing^Aff1, Zhou, Xuanyi, Yuan, Jin, Weng, Lietao, Yu, Zhuo^{Aff2, IDs1340202501060x_cor1}, Zheng, Junke^{Aff1, Aff2, IDs1340202501060x_cor2}, Chen, Chiqi^{Aff2, IDs1340202501060x_cor3}

The role of the immune system in progressive multifocal leukoencephalopathy: a comparative analysis of two cases following autologous and allogeneic hematopoietic stem cell transplantation

Mandelli, Biancamaria^{Aff1, IDs00277025062585_cor1}, Mazzarella, Roberta^Aff1, Corbingi, Andrea^{Aff2, IDs00277025062585_cor2}, Barbera, Elettra Ortu La, Perrone, Salvatore, Fanciullo, David, Lorenzon, Martina, Pacitto, Giada, Cenfra, Natalia, Mecarocci, Sergio, Asioli, Sofia, Pulsoni, Alessandro

Health-related quality of life in patients with aggressive non-Hodgkin lymphoma: results from the PETAL trial

Dührsen, Ulrich^{Aff1, IDs00277025064021_cor1}, Prange-Krex, Gabriele, Moeller, Regina, Held, Harald, Heil, Gerhard, Schwarzer, Andreas, Mahlmann, Stefan, Dienst, Ariane, Sandmann, Matthias, Maschmeyer, Georg, Schütte, Jochen, Hahn, Dennis, Heike, Michael, Nonnemacher, Michael, Hanoun, Christine, Hüttmann, Andreas

Polatuzumab Vedotin, zanubrutinib and rituximab (Pola-ZR) achieved rapid and deep response in untreated frail and elderly DLBCL

Ren, Yuhong^Aff1, Tan, Hui^Aff2, Zhuang, Jingli, Cheng, Luya, Yuan, Ling, Ji, Lili, Ke, Yang, Zhang, Xuejiao, Cheng, Zhixiang, Li, Jing, Liu, Peng^{Aff1, IDs0027702506412z_cor1}

Outcomes of the transformation to diffuse large B-cell lymphoma in hodgkin lymphoma and indolent B-cell non-Hodgkin lymphoma: a population-based study

Zheng, Wenshuai^Aff1, Peng, Bo^Aff2, Chen, Huaxin^Aff1, Wang, Shenyu^{Aff2, IDs0027702506395x_cor1}, Guan, Lixun^{Aff1, IDs0027702506395x_cor2}, Gao, Xiaoning^{Aff2, Aff3, IDs0027702506395x_cor3}